{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T15:02:37Z","timestamp":1784818957593,"version":"3.55.0"},"reference-count":110,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T00:00:00Z","timestamp":1784764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T00:00:00Z","timestamp":1784764800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100017170","name":"Thailand Science Research and Innovation","doi-asserted-by":"crossref","award":["C01F670185"],"award-info":[{"award-number":["C01F670185"]}],"id":[{"id":"10.13039\/501100017170","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Thailand Center for Excellence for Life Sciences","award":["TC (ERP) 31\/2568"],"award-info":[{"award-number":["TC (ERP) 31\/2568"]}]},{"DOI":"10.13039\/501100004704","name":"National Research Council of Thailand","doi-asserted-by":"publisher","award":["N42A680591, N35E680087"],"award-info":[{"award-number":["N42A680591, N35E680087"]}],"id":[{"id":"10.13039\/501100004704","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002873","name":"Chulalongkorn University","doi-asserted-by":"crossref","award":["RA-MF-22\/69 and CE68_028_3000_004"],"award-info":[{"award-number":["RA-MF-22\/69 and CE68_028_3000_004"]}],"id":[{"id":"10.13039\/501100002873","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neural Transm"],"DOI":"10.1007\/s00702-026-03239-4","type":"journal-article","created":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T14:18:42Z","timestamp":1784816322000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Plant-derived therapies in Parkinson\u2019s disease: a systematic review of clinical evidence"],"prefix":"10.1007","author":[{"given":"Narumol","family":"Sukmueng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Onanong","family":"Phokaewvarangkul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6901-2064","authenticated-orcid":false,"given":"Roongroj","family":"Bhidayasiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,23]]},"reference":[{"key":"3239_CR1","doi-asserted-by":"publisher","unstructured":"An Alternative Medicine Treatment for Parkinson\u2019s Disease: Results of a Multicenter Clinical Trial (1995) J Altern Complement Med 1(3):249\u2013255. https:\/\/doi.org\/10.1089\/acm.1995.1.249","DOI":"10.1089\/acm.1995.1.249"},{"key":"3239_CR2","doi-asserted-by":"publisher","unstructured":"Babayeva M, Assefa H, Basu P, Chumki S, Loewy Z (2016) Marijuana compounds: a nonconventional approach to Parkinson\u2019s disease therapy. Parkinsons Dis 2016(1279042). https:\/\/doi.org\/10.1155\/2016\/1279042","DOI":"10.1155\/2016\/1279042"},{"key":"3239_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jep.2017.07.022","volume":"209","author":"R Bahramsoltani","year":"2017","unstructured":"Bahramsoltani R, Rahimi R, Farzaei MH (2017) Pharmacokinetic interactions of curcuminoids with conventional drugs: a review. J Ethnopharmacol 209:1\u201312. https:\/\/doi.org\/10.1016\/j.jep.2017.07.022","journal-title":"J Ethnopharmacol"},{"key":"3239_CR4","doi-asserted-by":"publisher","first-page":"108185","DOI":"10.1016\/j.phrs.2026.108185","volume":"227","author":"GM Baldasso","year":"2026","unstructured":"Baldasso GM, Paes RS, Moreira AG, Salvadori SG, Limberger C, Roviezzo F, Capasso R, Dutra RC (2026) The role of cannabinoid ligands in neurodegenerative diseases: emerging anti-inflammatory, immunomodulation and disease-modifying perspectives. Pharmacol Res 227:108185. https:\/\/doi.org\/10.1016\/j.phrs.2026.108185","journal-title":"Pharmacol Res"},{"issue":"5","key":"3239_CR5","doi-asserted-by":"publisher","first-page":"868","DOI":"10.3390\/molecules31050868","volume":"31","author":"Z Bashev","year":"2026","unstructured":"Bashev Z, Karcheva-Bahchevanska D, Ardasheva R, Ivanova S (2026) A Comprehensive Review of the Therapeutic Potential of Mucuna pruriens. Molecules 31(5):868. https:\/\/doi.org\/10.3390\/molecules31050868","journal-title":"Molecules"},{"issue":"4","key":"3239_CR6","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1002\/ptr.5029","volume":"28","author":"S Benson","year":"2014","unstructured":"Benson S, Downey LA, Stough C, Wetherell M, Zangara A, Scholey A (2014) An acute, double-blind, placebo-controlled cross-over study of 320\u00a0mg and 640\u00a0mg doses of Bacopa monnieri (CDRI 08) on multitasking stress reactivity and mood. Phytother Res 28(4):551\u2013559. https:\/\/doi.org\/10.1002\/ptr.5029","journal-title":"Phytother Res"},{"issue":"10","key":"3239_CR7","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1159\/000521214","volume":"68","author":"AS Bhagavathula","year":"2022","unstructured":"Bhagavathula AS, Tesfaye W, Vidyasagar K, Fialova D (2022) Polypharmacy and hyperpolypharmacy in older individuals with Parkinson\u2019s disease: a systematic review and meta-analysis. Gerontology 68(10):1081\u20131090. https:\/\/doi.org\/10.1159\/000521214","journal-title":"Gerontology"},{"issue":"22","key":"3239_CR8","doi-asserted-by":"publisher","first-page":"e2194","DOI":"10.1212\/wnl.0000000000200113","volume":"98","author":"MA Bock","year":"2022","unstructured":"Bock MA, Brown EG, Zhang L, Tanner C (2022) Association of motor and nonmotor symptoms with health-related quality of life in a large online cohort of people with Parkinson disease. Neurology 98(22):e2194\u2013e2203. https:\/\/doi.org\/10.1212\/wnl.0000000000200113","journal-title":"Neurology"},{"issue":"11","key":"3239_CR9","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1007\/s00702-025-02914-2","volume":"132","author":"T Boonmongkol","year":"2025","unstructured":"Boonmongkol T, Phokaewvarangkul O, Vimolmangkang S, Wattanavijitkul T, Komenkul V, Bhidayasiri R (2025) Comparative efficacy of Mucuna pruriens and conventional levodopa in Parkinson\u2019s disease: a randomized controlled trial on pharmacokinetics and clinical perspectives from Asia. J Neural Transm (Vienna) 132(11):1673\u20131683. https:\/\/doi.org\/10.1007\/s00702-025-02914-2","journal-title":"J Neural Transm (Vienna)"},{"issue":"3","key":"3239_CR10","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1007\/s11418-017-1077-6","volume":"71","author":"P Boonruamkaew","year":"2017","unstructured":"Boonruamkaew P, Sukketsiri W, Panichayupakaranant P, Kaewnam W, Tanasawet S, Tipmanee V, Hutamekalin P, Chonpathompikunlert P (2017) Apium graveolens extract influences mood and cognition in healthy mice. J Nat Med 71(3):492\u2013505. https:\/\/doi.org\/10.1007\/s11418-017-1077-6","journal-title":"J Nat Med"},{"key":"3239_CR11","doi-asserted-by":"publisher","first-page":"e14568","DOI":"10.7717\/peerj.14568","volume":"11","author":"R Buathong","year":"2023","unstructured":"Buathong R, Duangsrisai S (2023) Plant ingredients in Thai food: a well-rounded diet for natural bioactive associated with medicinal properties. PeerJ 11:e14568. https:\/\/doi.org\/10.7717\/peerj.14568","journal-title":"PeerJ"},{"key":"3239_CR12","doi-asserted-by":"publisher","unstructured":"Burgaz S, Rodr\u00edguez-Carreiro S, Navarro E, Lastres-Becker I, Garc\u00eda-Arencibia M, Palomo-Garo C, G\u00f3mez-G\u00e1lvez Y, G\u00f3mez-Ca\u00f1as M, Garc\u00eda C, Fern\u00e1ndez-Ruiz J (2026) Development of cannabinoid-based therapies for Parkinson\u2019s disease: emphasis on targeting cannabinoid receptors as CB2, PPAR-\u03b3 and GPR55 receptors. Mol Neurodegener Adv 2(1). https:\/\/doi.org\/10.1186\/s44477-025-00016-7","DOI":"10.1186\/s44477-025-00016-7"},{"issue":"6","key":"3239_CR13","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1089\/acm.2008.0018","volume":"14","author":"C Calabrese","year":"2008","unstructured":"Calabrese C, Gregory WL, Leo M, Kraemer D, Bone K, Oken B (2008) Effects of a standardized Bacopa monnieri extract on cognitive performance, anxiety, and depression in the elderly: a randomized, double-blind, placebo-controlled trial. J Altern Complement Med (New York NY) 14(6):707\u2013713. https:\/\/doi.org\/10.1089\/acm.2008.0018","journal-title":"J Altern Complement Med (New York NY)"},{"key":"3239_CR14","doi-asserted-by":"publisher","first-page":"106983","DOI":"10.1016\/j.parkreldis.2024.106983","volume":"124","author":"S Caronni","year":"2024","unstructured":"Caronni S, Del Sorbo F, Barichella M, Fothergill-Misbah N, Denne T, Laguna J, Urasa S, Dekker MCJ, Akpalu A, Sarfo FS, Cham M, Pezzoli G, Cilia R (2024) Mucuna pruriens to treat Parkinson\u2019s disease in low-income countries: recommendations and practical guidelines from the farmer to clinical trials. Paving the way for future use in clinical practice. Parkinsonism Relat Disord 124:106983. https:\/\/doi.org\/10.1016\/j.parkreldis.2024.106983","journal-title":"Parkinsonism Relat Disord"},{"issue":"7","key":"3239_CR15","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1212\/01.wnl.0000140288.48796.8e","volume":"63","author":"CB Carroll","year":"2004","unstructured":"Carroll CB, Bain PG, Teare L, Liu X, Joint C, Wroath C, Parkin SG, Fox P, Wright D, Hobart J, Zajicek JP (2004) Cannabis for dyskinesia in Parkinson disease: a randomized double-blind crossover study. Neurology 63(7):1245\u20131250. https:\/\/doi.org\/10.1212\/01.wnl.0000140288.48796.8e","journal-title":"Neurology"},{"key":"3239_CR16","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.jns.2016.04.001","volume":"365","author":"E Cassani","year":"2016","unstructured":"Cassani E, Cilia R, Laguna J, Barichella M, Contin M, Cereda E, Isaias IU, Sparvoli F, Akpalu A, Budu KO, Scarpa MT, Pezzoli G (2016) Mucuna pruriens\u2009for Parkinson\u2019s disease: low-cost preparation method, laboratory measures and pharmacokinetics profile. J Neurol Sci 365:175\u2013180. https:\/\/doi.org\/10.1016\/j.jns.2016.04.001","journal-title":"J Neurol Sci"},{"key":"3239_CR17","doi-asserted-by":"publisher","unstructured":"Chagas MHN, Zuardi AW, Tumas V, Pena-Pereira MA, Sobreira ET, Bergamaschi MM, dos Santos AC, Teixeira AL, Hallak JE, Crippa JAS (2014) Effects of cannabidiol in the treatment of patients with Parkinson\u2019s disease: an exploratory double-blind trial. 28(11):1088\u20131098. https:\/\/doi.org\/10.1177\/0269881114550355","DOI":"10.1177\/0269881114550355"},{"issue":"1","key":"3239_CR18","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.jep.2010.11.045","volume":"134","author":"PD Charles","year":"2011","unstructured":"Charles PD, Ambigapathy G, Geraldine P, Akbarsha MA, Rajan KE (2011) Bacopa monniera leaf extract up-regulates tryptophan hydroxylase (TPH2) and serotonin transporter (SERT) expression: implications in memory formation. J Ethnopharmacol 134(1):55\u201361. https:\/\/doi.org\/10.1016\/j.jep.2010.11.045","journal-title":"J Ethnopharmacol"},{"issue":"3","key":"3239_CR19","doi-asserted-by":"publisher","first-page":"3884","DOI":"10.3892\/mmr.2017.8332","volume":"17","author":"Y Chen","year":"2018","unstructured":"Chen Y, Jiang M, Li L, Ye M, Yu M, Zhang L, Ge B, Xu W, Wei D (2018) DL\u20133\u2013n\u2013butylphthalide reduces microglial activation in lipopolysaccharide\u2013induced Parkinson\u2019s disease model mice. Mol Med Rep 17(3):3884\u20133890. https:\/\/doi.org\/10.3892\/mmr.2017.8332","journal-title":"Mol Med Rep"},{"key":"3239_CR20","unstructured":"Chevallier A (2023) Encyclopedia of herbal medicine, 4th edn. London"},{"issue":"1","key":"3239_CR21","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1186\/s12906-018-2166-0","volume":"18","author":"P Chonpathompikunlert","year":"2018","unstructured":"Chonpathompikunlert P, Boonruamkaew P, Sukketsiri W, Hutamekalin P, Sroyraya M (2018) The antioxidant and neurochemical activity of Apium graveolens L. and its ameliorative effect on MPTP-induced Parkinson-like symptoms in mice. BMC Complement Altern Med 18(1):103. https:\/\/doi.org\/10.1186\/s12906-018-2166-0","journal-title":"BMC Complement Altern Med"},{"issue":"5","key":"3239_CR22","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1212\/wnl.0000000000004175","volume":"89","author":"R Cilia","year":"2017","unstructured":"Cilia R, Laguna J, Cassani E, Cereda E, Pozzi NG, Isaias IU, Contin M, Barichella M, Pezzoli G (2017) Mucuna pruriens in Parkinson disease: a double-blind, randomized, controlled, crossover study. Neurology 89(5):432\u2013438. https:\/\/doi.org\/10.1212\/wnl.0000000000004175","journal-title":"Neurology"},{"key":"3239_CR23","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.parkreldis.2018.01.014","volume":"49","author":"R Cilia","year":"2018","unstructured":"Cilia R, Laguna J, Cassani E, Cereda E, Raspini B, Barichella M, Pezzoli G (2018) Daily intake of Mucuna pruriens in advanced Parkinson\u2019s disease: a 16-week, noninferiority, randomized, crossover, pilot study. Parkinsonism Relat Disord 49:60\u201366. https:\/\/doi.org\/10.1016\/j.parkreldis.2018.01.014","journal-title":"Parkinsonism Relat Disord"},{"key":"3239_CR24","doi-asserted-by":"publisher","first-page":"100039","DOI":"10.1016\/j.prerep.2025.100039","volume":"3","author":"G Daoud","year":"2025","unstructured":"Daoud G, Ahsan F, Mahmood T, Bano S, Ansari VA, Zaidi SMH, Ansari JA (2025) Therapeutic potential and bioactive compounds of Apium graveolens: a phytopharmacological review. Pharmacol Res Rep 3:100039. https:\/\/doi.org\/10.1016\/j.prerep.2025.100039","journal-title":"Pharmacol Res Rep"},{"issue":"7","key":"3239_CR25","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1002\/mds.28577","volume":"36","author":"CMO de Almeida","year":"2021","unstructured":"de Almeida CMO, Brito MMC, Bosaipo NB, Pimentel AV, Tumas V, Zuardi AW, Crippa JAS, Hallak JEC, Eckeli AL (2021) Cannabidiol for rapid eye movement sleep behavior disorder. Mov Disord Off J Mov Disord Soc 36(7):1711\u20131715. https:\/\/doi.org\/10.1002\/mds.28577","journal-title":"Mov Disord Off J Mov Disord Soc"},{"issue":"2","key":"3239_CR26","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1177\/0269881119895536","volume":"34","author":"SM de Faria","year":"2020","unstructured":"de Faria SM, de Morais Fabr\u00edcio D, Tumas V, Castro PC, Ponti MA, Hallak JE, Zuardi AW, Crippa JAS, Chagas MHN (2020) Effects of acute cannabidiol administration on anxiety and tremors induced by a simulated public speaking test in patients with Parkinson\u2019s disease. J Psychopharmacol (Oxford England) 34(2):189\u2013196. https:\/\/doi.org\/10.1177\/0269881119895536","journal-title":"J Psychopharmacol (Oxford England)"},{"issue":"5","key":"3239_CR27","doi-asserted-by":"publisher","first-page":"102990","DOI":"10.1016\/j.explore.2024.02.008","volume":"20","author":"M Delfan","year":"2024","unstructured":"Delfan M, Kordestani-Moghaddam P, Gholami M, Kazemi K, Mohammadi R (2024) Evaluating the effects of Bacopa monnieri on cognitive performance and sleep quality of patients with mild cognitive impairment: a triple-blinded, randomized, placebo-controlled trial. Explore 20(5):102990. https:\/\/doi.org\/10.1016\/j.explore.2024.02.008","journal-title":"Explore"},{"issue":"7","key":"3239_CR28","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1002\/mds.29447","volume":"38","author":"CH Domen","year":"2023","unstructured":"Domen CH, Sillau S, Liu Y, Adkins M, Rajkovic S, Bainbridge J, Sempio C, Klawitter J, Leehey MA (2023) Cognitive safety data from a randomized, double-blind, parallel-group, placebo-controlled phase IIb study of the effects of a cannabidiol and \u03949-tetrahydrocannabinol drug on Parkinson's disease-related motor symptoms. Mov Disord Off J Mov Disorder Soc 38 (7):1341\u20131346. doi:https:\/\/doi.org\/10.1002\/mds.29447","journal-title":"Mov Disord Off J Mov Disorder Soc"},{"issue":"7","key":"3239_CR29","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1093\/jnen\/nlac034","volume":"81","author":"V Donadio","year":"2022","unstructured":"Donadio V, Incensi A, Rizzo G, Fileccia E, Ventruto F, Riva A, Tiso D, Recchia M, Vacchiano V, Infante R, Petrangolini G, Allegrini P, Avino S, Pantieri R, Mostacci B, Avoni P, Liguori R (2022) The effect of curcumin on idiopathic parkinson disease: a clinical and skin biopsy study. J Neuropathol Exp Neurol 81(7):545\u2013552. https:\/\/doi.org\/10.1093\/jnen\/nlac034","journal-title":"J Neuropathol Exp Neurol"},{"key":"3239_CR30","doi-asserted-by":"publisher","first-page":"e82891","DOI":"10.2196\/82891","volume":"15","author":"A Dwivedi","year":"2026","unstructured":"Dwivedi A, Anjali A, Narzari H, Kumar Y, Sharma HP, Dubey A, Nilima N, Rajan R, Bhushan Singh M, Vishnu VY, Bhatia R, Sharma G, Gupta A (2026) Efficacy of Bacopa monnieri (Linn.) on cognitive function and alterations in blood metabolites in patients with amnestic mild cognitive impairment and early alzheimer disease: protocol for an exploratory double-blind, randomized, placebo-controlled trial. JMIR Res Protoc 15:e82891. https:\/\/doi.org\/10.2196\/82891","journal-title":"JMIR Res Protoc"},{"key":"3239_CR31","doi-asserted-by":"publisher","first-page":"149414","DOI":"10.1016\/j.brainres.2024.149414","volume":"1850","author":"AG Erustes","year":"2025","unstructured":"Erustes AG, Ab\u00edlio VC, Bincoletto C, Piacentini M, Pereira GJS, Smaili SS (2025) Cannabidiol induces autophagy via CB(1) receptor and reduces \u03b1-synuclein cytosolic levels. Brain Res 1850:149414. https:\/\/doi.org\/10.1016\/j.brainres.2024.149414","journal-title":"Brain Res"},{"key":"3239_CR32","doi-asserted-by":"publisher","DOI":"10.5772\/57102","volume-title":"A Synopsis of Parkinson\u2019s disease","author":"B Flor\u00e1n-Gardu\u00f1o","year":"2014","unstructured":"Flor\u00e1n-Gardu\u00f1o B, Bravo SA, Rangel-Barajas C (2014) Pathophysiology of L-dopa induced dyskinesia\u2014changes in D1\/D3 receptors and their signaling pathway. In: Rana MFFAQ (ed) A Synopsis of Parkinson\u2019s disease. IntechOpen, London. doi:https:\/\/doi.org\/10.5772\/57102"},{"issue":"10423","key":"3239_CR33","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/s0140-6736(23)01429-0","volume":"403","author":"T Foltynie","year":"2024","unstructured":"Foltynie T, Bruno V, Fox S, K\u00fchn AA, Lindop F, Lees AJ (2024) Medical, surgical, and physical treatments for Parkinson\u2019s disease. Lancet 403(10423):305\u2013324. https:\/\/doi.org\/10.1016\/s0140-6736(23)01429-0","journal-title":"Lancet"},{"key":"3239_CR34","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.parkreldis.2020.03.002","volume":"73","author":"N Fothergill-Misbah","year":"2020","unstructured":"Fothergill-Misbah N, Maroo H, Cham M, Pezzoli G, Walker R, Cilia R (2020) Could Mucuna pruriens be the answer to Parkinson\u2019s disease management in sub-Saharan Africa and other low-income countries worldwide? Parkinsonism Relat Disord 73:3\u20137. https:\/\/doi.org\/10.1016\/j.parkreldis.2020.03.002","journal-title":"Parkinsonism Relat Disord"},{"key":"3239_CR35","doi-asserted-by":"publisher","first-page":"111888","DOI":"10.1016\/j.biopha.2021.111888","volume":"141","author":"Y-S Fu","year":"2021","unstructured":"Fu Y-S, Chen T-H, Weng L, Huang L, Lai D, Weng C-F (2021) Pharmacological properties and underlying mechanisms of curcumin and prospects in medicinal potential. Biomed Pharmacother 141:111888. https:\/\/doi.org\/10.1016\/j.biopha.2021.111888","journal-title":"Biomed Pharmacother"},{"issue":"11","key":"3239_CR36","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1016\/j.eprac.2023.08.009","volume":"29","author":"E Gatta","year":"2023","unstructured":"Gatta E, Maltese V, Cavadini M, Anelli V, Bambini F, Buoso C, Facondo P, Pirola I, Delbarba A, Cappelli C (2023) Interference or noninterference between soy and levothyroxine: that is the question. A narrative review of literature. Endocr Pract 29(11):897\u2013901. https:\/\/doi.org\/10.1016\/j.eprac.2023.08.009","journal-title":"Endocr Pract"},{"key":"3239_CR37","doi-asserted-by":"publisher","first-page":"107300","DOI":"10.1016\/j.clineuro.2022.107300","volume":"218","author":"H Ghodsi","year":"2022","unstructured":"Ghodsi H, Rahimi HR, Aghili SM, Saberi A, Shoeibi A (2022) Evaluation of curcumin as add-on therapy in patients with Parkinson\u2019s disease: a pilot randomized, triple-blind, placebo-controlled trial. Clin Neurol Neurosurg 218:107300. https:\/\/doi.org\/10.1016\/j.clineuro.2022.107300","journal-title":"Clin Neurol Neurosurg"},{"key":"3239_CR38","doi-asserted-by":"publisher","first-page":"105406","DOI":"10.1016\/j.parkreldis.2023.105406","volume":"112","author":"T Goldberg","year":"2023","unstructured":"Goldberg T, Redlich Y, Yogev D, Fay-Karmon T, Hassin-Baer S, Anis S (2023) Long-term safety of medical cannabis in Parkinson\u2019s disease: a retrospective case-control study. Parkinsonism Relat Disord 112:105406. https:\/\/doi.org\/10.1016\/j.parkreldis.2023.105406","journal-title":"Parkinsonism Relat Disord"},{"key":"3239_CR39","doi-asserted-by":"publisher","unstructured":"Go\u015bciniak A, Stasi\u0142owicz-Krzemie\u0144 A, Szel\u0105g M, Pawlak J, Skiera I, Kwiatkowska H, Nowak N, Bernady K, Trzaskoma P, Zimak-Kr\u00f3tkopad O, Cielecka-Piontek J (2025) Bacopa monnieri: preclinical and clinical evidence of neuroactive effects, safety of use and the search for improved bioavailability. Nutrients 17(11). https:\/\/doi.org\/10.3390\/nu17111939","DOI":"10.3390\/nu17111939"},{"key":"3239_CR40","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.3389\/fphar.2019.01119","volume":"10","author":"Y Goshima","year":"2019","unstructured":"Goshima Y, Masukawa D, Kasahara Y, Hashimoto T, Aladeokin AC (2019) l-DOPA and its receptor GPR143: implications for pathogenesis and therapy in Parkinson\u2019s disease. Front Pharmacol 10:1119. https:\/\/doi.org\/10.3389\/fphar.2019.01119","journal-title":"Front Pharmacol"},{"issue":"3","key":"3239_CR41","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1080\/14728214.2025.2517582","volume":"30","author":"P Gros","year":"2025","unstructured":"Gros P, Armengou Garcia L, Fox SH (2025) Motor fluctuations in Parkinson disease: a mini-review of emerging drugs. Expert Opin Emerg Drugs 30(3):179\u2013190. https:\/\/doi.org\/10.1080\/14728214.2025.2517582","journal-title":"Expert Opin Emerg Drugs"},{"issue":"1","key":"3239_CR42","doi-asserted-by":"publisher","first-page":"20241075","DOI":"10.1515\/med-2024-1075","volume":"19","author":"EG Hafida","year":"2024","unstructured":"Hafida EG, Rachid S, Halima G, Najib K (2024) CBD\u2019s potential impact on Parkinson\u2019s disease: an updated overview. Open Med (Wars) 19(1):20241075. https:\/\/doi.org\/10.1515\/med-2024-1075","journal-title":"Open Med (Wars)"},{"key":"3239_CR43","doi-asserted-by":"publisher","unstructured":"Hammoud F, Ismail A, Zaher R, El Majzoub R, Abou-Abbas L (2025) Mucuna pruriens treatment for Parkinson disease: a systematic review of clinical trials. Parkinsons Dis 2025(1319419). https:\/\/doi.org\/10.1155\/padi\/1319419","DOI":"10.1155\/padi\/1319419"},{"issue":"11","key":"3239_CR44","doi-asserted-by":"publisher","first-page":"3010","DOI":"10.1111\/jcmm.13212","volume":"21","author":"Z He","year":"2017","unstructured":"He Z, Zhou Y, Lin L, Wang Q, Khor S, Mao Y, Li J, Zhen Z, Chen J, Gao Z, Wu F, Zhang X, Zhang H, Xu HZ, Wang Z, Xiao J (2017) Dl-3-n-butylphthalide attenuates acute inflammatory activation in rats with spinal cord injury by inhibiting microglial TLR4\/NF-\u03baB signalling. J Cell Mol Med 21(11):3010\u20133022. https:\/\/doi.org\/10.1111\/jcmm.13212","journal-title":"J Cell Mol Med"},{"issue":"49","key":"3239_CR45","doi-asserted-by":"publisher","first-page":"833","DOI":"10.3238\/arztebl.m2023.0223","volume":"120","author":"T Herdegen","year":"2023","unstructured":"Herdegen T, Cascorbi I (2023) Drug interactions of tetrahydrocannabinol and cannabidiol in cannabinoid drugs. Dtsch Arztebl Int 120(49):833\u2013840. https:\/\/doi.org\/10.3238\/arztebl.m2023.0223","journal-title":"Dtsch Arztebl Int"},{"key":"3239_CR81","doi-asserted-by":"publisher","first-page":"5042","DOI":"10.26355\/eurrev_201808_15647","volume":"15","author":"S Hu","year":"2018","unstructured":"Hu S, Dugall GBM, Peterzan P, Hosoi M, Ledda A, Riva A, Giacomelli L, Togni S, Eggenhoffner R, Cotellese R (2018) Interaction study between antiplatelet agents, anticoagulants, thyroid replacement therapy and a bioavailable formulation of curcumin (Meriva\u00ae). Eur Rev Med Pharmacol Sci 15:5042\u20135046. https:\/\/doi.org\/10.26355\/eurrev_201808_15647","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"1","key":"3239_CR46","doi-asserted-by":"publisher","first-page":"194","DOI":"10.4103\/1673-5374.343892","volume":"18","author":"CB Hu","year":"2023","unstructured":"Hu CB, Jiang H, Yang Y, Wang GH, Ji QH, Jia ZZ, Shen LH, Luo QQ (2023) DL-3-n-butylphthalide alleviates motor disturbance by suppressing ferroptosis in a rat model of Parkinson\u2019s disease. Neural regener Res 18(1):194\u2013199. https:\/\/doi.org\/10.4103\/1673-5374.343892","journal-title":"Neural Regener Res"},{"issue":"6","key":"3239_CR47","doi-asserted-by":"publisher","first-page":"2256","DOI":"10.1002\/jsfa.10846","volume":"101","author":"J Jittiwat","year":"2021","unstructured":"Jittiwat J, Chonpathompikunlert P, Sukketsiri W (2021) Neuroprotective effects of Apium graveolens against focal cerebral ischemia occur partly via antioxidant, anti-inflammatory, and anti-apoptotic pathways. J Sci Food Agric 101(6):2256\u20132263. https:\/\/doi.org\/10.1002\/jsfa.10846","journal-title":"J Sci Food Agric"},{"issue":"1","key":"3239_CR48","doi-asserted-by":"publisher","first-page":"110","DOI":"10.33545\/26647206.2025.v7.i1b.30","volume":"7","author":"M Kakade","year":"2025","unstructured":"Kakade M, Patil SA (2025) Bacopa monnieri in cognitive pharmacology: mechanisms, bio active compounds and clinical applications. Int J Pharmacol Pharm Sci 7(1):110\u2013113. https:\/\/doi.org\/10.33545\/26647206.2025.v7.i1b.30","journal-title":"Int J Pharmacol Pharm Sci"},{"issue":"4","key":"3239_CR49","doi-asserted-by":"publisher","first-page":"663","DOI":"10.25259\/jnrp-2022-6-19","volume":"13","author":"A Kanjanarangsichai","year":"2022","unstructured":"Kanjanarangsichai A, Mitarnun W, Mitarnun W, Pangwong W, Laoharattanahirun N, Kajornrith W, Junlaor P, Nonghan P, Witthayapirote W, Sangkarom G (2022) Cannabidiol-enriched cannabis extraction product in Parkinson\u2019s disease: a randomized, double-blind, and placebo-controlled trial in Buriram Hospital. J Neurosci Rural Pract 13(4):663\u2013668. https:\/\/doi.org\/10.25259\/jnrp-2022-6-19","journal-title":"J Neurosci Rural Pract"},{"key":"3239_CR50","doi-asserted-by":"publisher","unstructured":"Katzenschlager R, Evans A, Manson A, Patsalos PN, Ratnaraj N, Watt H, Timmermann L,Van der Giessen R, Lees AJ (2004) Mucuna pruriens in Parkinson\u2019s disease: a double blind clinical and pharmacological study. J Neurol Neurosurg Psychiatry 75 (12):1672. https:\/\/doi.org\/10.1136\/jnnp.2003.028761","DOI":"10.1136\/jnnp.2003.028761"},{"key":"3239_CR51","doi-asserted-by":"publisher","unstructured":"Kumari N, Anand S, Shah K, Chauhan NS, Sethiya NK, Singhal M (2023) Emerging role of plant-based bioactive compounds as therapeutics in Parkinson\u2019s disease. Molecules 28(22). https:\/\/doi.org\/10.3390\/molecules28227588","DOI":"10.3390\/molecules28227588"},{"key":"3239_CR52","doi-asserted-by":"publisher","unstructured":"Kusuma S, Setiawan A, Salni S (2018) The capability of sedative effect from celery (Apium graveolens L.) fraction to male mice. Biovalentia Biol Res J 4. https:\/\/doi.org\/10.24233\/BIOV.4.2.2018.111","DOI":"10.24233\/BIOV.4.2.2018.111"},{"key":"3239_CR53","doi-asserted-by":"publisher","first-page":"108568","DOI":"10.1016\/j.biotechadv.2025.108568","volume":"82","author":"R Lagoa","year":"2025","unstructured":"Lagoa R, Rajan L, Violante C, Babiaka SB, Marques-da-Silva D, Kapoor B, Reis F, Atanasov AG (2025) Application of curcuminoids in inflammatory, neurodegenerative and aging conditions\u2014pharmacological potential and bioengineering approaches to improve efficiency. Biotechnol Adv 82:108568. https:\/\/doi.org\/10.1016\/j.biotechadv.2025.108568","journal-title":"Biotechnol Adv"},{"issue":"3","key":"3239_CR54","doi-asserted-by":"publisher","first-page":"196","DOI":"10.9758\/cpn.2014.12.3.196","volume":"12","author":"SH Lin","year":"2014","unstructured":"Lin SH, Lee LT, Yang YK (2014) Serotonin and mental disorders: a concise review on molecular neuroimaging evidence. Clin Psychopharmacol Neurosci 12(3):196\u2013202. https:\/\/doi.org\/10.9758\/cpn.2014.12.3.196","journal-title":"Clin Psychopharmacol Neurosci"},{"issue":"8","key":"3239_CR56","doi-asserted-by":"publisher","first-page":"694","DOI":"10.3109\/1061186X.2016.1157883","volume":"24","author":"W Liu","year":"2016","unstructured":"Liu W, Zhai Y, Heng X, Che FY, Chen W, Sun D, Zhai G (2016) Oral bioavailability of curcumin: problems and advancements. J Drug Target 24(8):694\u2013702. https:\/\/doi.org\/10.3109\/1061186X.2016.1157883","journal-title":"J Drug Target"},{"issue":"5","key":"3239_CR57","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1002\/mds.29768","volume":"39","author":"Y Liu","year":"2024","unstructured":"Liu Y, Bainbridge J, Sillau S, Rajkovic S, Adkins M, Domen CH, Thompson JA, Seawalt T, Klawitter J, Sempio C, Chin G, Forman L, Fullard M, Hawkins T, Seeberger L, Newman H, Vu D, Leehey MA (2024) Short-term cannabidiol with \u2206-9-Tetrahydrocannabinol in Parkinson\u2019s disease: a randomized trial. Mov Disord Off J Mov Disord Soc 39(5):863\u2013875. https:\/\/doi.org\/10.1002\/mds.29768","journal-title":"Mov Disord Off J Mov Disord Soc"},{"key":"3239_CR55","doi-asserted-by":"publisher","unstructured":"Liu M, Wang J, Song Z, Pei Y (2025) Regulation mechanism of curcumin mediated inflammatory pathway and its clinical application: a review. Front Pharmacol 16\u20132025. https:\/\/doi.org\/10.3389\/fphar.2025.1642248","DOI":"10.3389\/fphar.2025.1642248"},{"issue":"12","key":"3239_CR58","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1007\/s40261-025-01492-1","volume":"45","author":"AL Lopresti","year":"2025","unstructured":"Lopresti AL, Smith SJ (2025) The effects of a Bacopa monnieri extract (Bacumen\u00ae) on cognition, stress, and fatigue in healthy adults: a randomized, double-blind, placebo-controlled trial. Clin Drug Investig 45(12):967\u2013982. https:\/\/doi.org\/10.1007\/s40261-025-01492-1","journal-title":"Clin Drug Investig"},{"key":"3239_CR59","doi-asserted-by":"publisher","first-page":"104671","DOI":"10.1016\/j.jff.2021.104671","volume":"85","author":"AL Lopresti","year":"2021","unstructured":"Lopresti AL, Smith SJ, Ali S, Metse AP, Kalns J, Drummond PD (2021) Effects of a Bacopa monnieri extract (Bacognize\u00ae) on stress, fatigue, quality of life and sleep in adults with self-reported poor sleep: a randomised, double-blind, placebo-controlled study. J Funct Foods 85:104671. https:\/\/doi.org\/10.1016\/j.jff.2021.104671","journal-title":"J Funct Foods"},{"issue":"3","key":"3239_CR60","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1002\/mds.23462","volume":"26","author":"P Martinez-Martin","year":"2011","unstructured":"Martinez-Martin P, Rodriguez-Blazquez C, Kurtis MM, Chaudhuri KR (2011) The impact of non-motor symptoms on health-related quality of life of patients with Parkinson\u2019s disease. Mov Disord Off J Mov Disord Soc 26(3):399\u2013406. https:\/\/doi.org\/10.1002\/mds.23462","journal-title":"Mov Disord Off J Mov Disord Soc"},{"key":"3239_CR61","doi-asserted-by":"publisher","unstructured":"McPhee GM, Downey LA, Wesnes KA, Stough C (2021) The neurocognitive effects of Bacopa monnieri and cognitive training on markers of brain microstructure in healthy older adults. Front Aging Neurosci. https:\/\/doi.org\/10.3389\/fnagi.2021.638109","DOI":"10.3389\/fnagi.2021.638109"},{"key":"3239_CR62","unstructured":"Medicine OCfE-B (2019) Oxford Centre for evidence-based medicine: levels of evidence. https:\/\/www.cebm.ox.ac.uk\/resources\/levels-of-evidence\/oxford-centre-for-evidence-based-medicine-levels-of-evidence-march-2009. Accessed April 2025"},{"key":"3239_CR63","doi-asserted-by":"publisher","first-page":"107841","DOI":"10.1016\/j.parkreldis.2025.107841","volume":"135","author":"W Mitarnun","year":"2025","unstructured":"Mitarnun W, Kanjanarangsichai A, Junlaor P, Kongngern L, Mitarnun W, Pangwong W, Nonghan P (2025) Cannabidiol and cognitive functions\/inflammatory markers in Parkinson\u2019s disease: a double-blind randomized controlled trial at Buriram Hospital (CBD-PD-BRH trial). Parkinsonism Relat Disord 135:107841. https:\/\/doi.org\/10.1016\/j.parkreldis.2025.107841","journal-title":"Parkinsonism Relat Disord"},{"issue":"1","key":"3239_CR64","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s13024-015-0012-0","volume":"10","author":"SV More","year":"2015","unstructured":"More SV, Choi D-K (2015) Promising cannabinoid-based therapies for Parkinson\u2019s disease: motor symptoms to neuroprotection. Mol Neurodegener 10(1):17. https:\/\/doi.org\/10.1186\/s13024-015-0012-0","journal-title":"Mol Neurodegener"},{"key":"3239_CR65","doi-asserted-by":"publisher","DOI":"10.5772\/62438","volume-title":"Cannabinoids in health and disease","author":"T Morera-Herreras","year":"2016","unstructured":"Morera-Herreras T, Torrecilla M, Miguelez C, Aristieta A, Ruiz-Ortega JA, Ugedo L (2016) Cannabinoids and motor control of the basal ganglia: therapeutic potential in movement disorders. In: Meccariello R, Chianese R (eds) Cannabinoids in health and disease. IntechOpen, London. doi:https:\/\/doi.org\/10.5772\/62438"},{"issue":"12","key":"3239_CR66","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1007\/s40263-017-0478-0","volume":"31","author":"S M\u00fcller-Rebstein","year":"2017","unstructured":"M\u00fcller-Rebstein S, Trenkwalder C, Ebentheuer J, Oertel WH, Culmsee C, H\u00f6glinger GU (2017) Drug safety analysis in a real-life cohort of Parkinson\u2019s disease patients with polypharmacy. CNS Drugs 31(12):1093\u20131102. https:\/\/doi.org\/10.1007\/s40263-017-0478-0","journal-title":"CNS Drugs"},{"issue":"5","key":"3239_CR67","doi-asserted-by":"publisher","first-page":"968","DOI":"10.3390\/biomedicines14050968","volume":"14","author":"T Mu\u0161i\u0107","year":"2026","unstructured":"Mu\u0161i\u0107 T, Turn\u0161ek TL (2026) The endocannabinoid system in neuropsychiatric disorders: mechanisms, dysregulation and therapeutic potential. Biomedicines 14(5):968. https:\/\/doi.org\/10.3390\/biomedicines14050968","journal-title":"Biomedicines"},{"key":"3239_CR68","doi-asserted-by":"publisher","unstructured":"Nagashima Y, Kondo T, Sakata M, Koh J, Ito H (2016) Effects of soybean ingestion on pharmacokinetics of levodopa and motor symptoms of Parkinson\u2019s disease\u2014in relation to the effects of Mucuna pruriens. J Neurol Sci 361:229\u2013234. https:\/\/doi.org\/10.1016\/j.jns.2016.01.005","DOI":"10.1016\/j.jns.2016.01.005"},{"key":"3239_CR69","doi-asserted-by":"publisher","unstructured":"Nebrisi EE (2021) Neuroprotective activities of curcumin in Parkinson\u2019s disease: a review of the literature. Int J Mol Sci 22(20). https:\/\/doi.org\/10.3390\/ijms222011248","DOI":"10.3390\/ijms222011248"},{"key":"3239_CR70","doi-asserted-by":"publisher","unstructured":"Nishanth JB, Vijayababu P, K Kurian N (2023) Bacopa monnieri extract as a neuroprotective and cognitive enhancement agent. Int J Drug Discov Pharmacol 2. https:\/\/doi.org\/10.53941\/ijddp.2023.100015","DOI":"10.53941\/ijddp.2023.100015"},{"key":"3239_CR71","doi-asserted-by":"publisher","unstructured":"Oliveira SMR, Girol AP, Nissapatorn V, Pereira ML (2025) Bioactive compounds derived from plants and their medicinal potential. Pharmaceuticals (Basel) 18(11). https:\/\/doi.org\/10.3390\/ph18111732","DOI":"10.3390\/ph18111732"},{"key":"3239_CR72","doi-asserted-by":"publisher","first-page":"1199516","DOI":"10.3389\/fphar.2023.1199516","volume":"14","author":"A Panossian","year":"2023","unstructured":"Panossian A (2023) Challenges in phytotherapy research. Front Pharmacol 14:1199516. https:\/\/doi.org\/10.3389\/fphar.2023.1199516","journal-title":"Front Pharmacol"},{"issue":"5","key":"3239_CR73","doi-asserted-by":"publisher","first-page":"e25032","DOI":"10.7759\/cureus.25032","volume":"14","author":"A Patel","year":"2022","unstructured":"Patel A, Olang CA, Lewis G, Mandalaneni K, Anand N, Gorantla VR (2022) An overview of Parkinson\u2019s disease: curcumin as a possible alternative treatment. Cureus 14(5):e25032. https:\/\/doi.org\/10.7759\/cureus.25032","journal-title":"Cureus"},{"issue":"6","key":"3239_CR74","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1007\/s13205-020-02253-x","volume":"10","author":"R Pathania","year":"2020","unstructured":"Pathania R, Chawla P, Khan H, Kaushik R, Khan MA (2020) An assessment of potential nutritive and medicinal properties of Mucuna pruriens: a natural food legume. 3 Biotech 10(6):261. https:\/\/doi.org\/10.1007\/s13205-020-02253-x","journal-title":"3 Biotech"},{"key":"3239_CR75","doi-asserted-by":"publisher","unstructured":"Patricio F, Morales-Andrade AA, Patricio-Mart\u00ednez A, Lim\u00f3n ID (2020) Cannabidiol as a therapeutic target: evidence of its neuroprotective and neuromodulatory function in Parkinson\u2019s disease. Front Pharmacol. https:\/\/doi.org\/10.3389\/fphar.2020.595635","DOI":"10.3389\/fphar.2020.595635"},{"key":"3239_CR76","doi-asserted-by":"publisher","unstructured":"Peth-Nui T, Wattanathorn J, Muchimapura S, Tong-Un T, Piyavhatkul N, Rangseekajee P, Ingkaninan K, Vittaya-Areekul S (2012) Effects of 12-week Bacopa monnieri consumption on attention, cognitive processing, working memory, and functions of both cholinergic and monoaminergic systems in healthy elderly volunteers. Evid Based Complement Alternat Med 2012:606424. https:\/\/doi.org\/10.1155\/2012\/606424","DOI":"10.1155\/2012\/606424"},{"issue":"3","key":"3239_CR77","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1002\/mdc3.12170","volume":"2","author":"ML Rabin","year":"2015","unstructured":"Rabin ML, Stevens-Haas C, Havrilla E, Rosenstein A, Toffey B, Devi T, Earnhardt MC, Kurlan R (2015) Complementary therapies for Parkinson\u2019s disease: what\u2019s promoted, rationale, potential risks and benefits. Mov Disord Clin Pract 2(3):205\u2013212. https:\/\/doi.org\/10.1002\/mdc3.12170","journal-title":"Mov Disord Clin Pract"},{"issue":"2","key":"3239_CR78","doi-asserted-by":"publisher","first-page":"2588","DOI":"10.3390\/molecules19022588","volume":"19","author":"S Ramasamy","year":"2014","unstructured":"Ramasamy S, Kiew LV, Chung LY (2014) Inhibition of human cytochrome P450 enzymes by Bacopa monnieri standardized extract and constituents. Molecules 19(2):2588\u20132601. https:\/\/doi.org\/10.3390\/molecules19022588","journal-title":"Molecules"},{"issue":"6","key":"3239_CR79","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1007\/s00702-025-02893-4","volume":"132","author":"P Riederer","year":"2025","unstructured":"Riederer P, Strobel S, Nagatsu T, Watanabe H, Chen X, L\u00f6schmann PA, Sian-Hulsmann J, Jost WH, M\u00fcller T, Dijkstra JM, Monoranu CM (2025) Levodopa treatment: impacts and mechanisms throughout Parkinson\u2019s disease progression. J Neural Transm (Vienna) 132(6):743\u2013779. https:\/\/doi.org\/10.1007\/s00702-025-02893-4","journal-title":"J Neural Transm (Vienna)"},{"issue":"1","key":"3239_CR80","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1038\/s41531-023-00541-w","volume":"9","author":"C Rusch","year":"2023","unstructured":"Rusch C, Flanagan R, Suh H, Subramanian I (2023) To restrict or not to restrict? Practical considerations for optimizing dietary protein interactions on levodopa absorption in Parkinson\u2019s disease. NPJ Parkinsons Dis 9(1):98. https:\/\/doi.org\/10.1038\/s41531-023-00541-w","journal-title":"NPJ Parkinsons Dis"},{"key":"3239_CR82","unstructured":"Sahib Z, Mamoori A, Al-Humairi I, Al-Mukhtar E (2021) The effect of apium graveolens seeds methanolic extracts on anxiety and the gaba a gene expression in male mice. PharmacologyOnline 1:472\u2013479"},{"issue":"20","key":"3239_CR83","doi-asserted-by":"publisher","first-page":"2773","DOI":"10.2169\/internalmedicine.3171-23","volume":"63","author":"M Sakata","year":"2024","unstructured":"Sakata M, Miyamoto K, Koh J, Nagashima Y, Kondo T, Ito H (2024) Japanese\u2009 Mucuna pruriens (Hasshou Beans) showed fast-acting and long-lasting effects in Parkinson\u2019s disease. Intern Med 63(20):2773\u20132779. https:\/\/doi.org\/10.2169\/internalmedicine.3171-23","journal-title":"Intern Med"},{"issue":"2","key":"3239_CR84","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1089\/jmf.2022.0106","volume":"26","author":"AF Santos","year":"2023","unstructured":"Santos AF, Souza MMQ, Amaral EC, Albuquerque ER, Bortoloti DS, Gasparotto Junior A, Louren\u00e7o ELB, Lovato ECW, L\u00edvero FAR (2023) Bacopa monnieri in patients with Parkinson\u2019s disease: a pilot study. J Med Food 26(2):114\u2013119. https:\/\/doi.org\/10.1089\/jmf.2022.0106","journal-title":"J Med Food"},{"issue":"7","key":"3239_CR85","doi-asserted-by":"publisher","first-page":"2889","DOI":"10.1002\/ptr.7469","volume":"36","author":"M Shayani Rad","year":"2022","unstructured":"Shayani Rad M, Moohebati M, Mohajeri SA (2022) Effect of celery (Apium graveolens) seed extract on hypertension: a randomized, triple-blind, placebo-controlled, cross-over, clinical trial. Phytother Res 36(7):2889\u20132907. https:\/\/doi.org\/10.1002\/ptr.7469","journal-title":"Phytother Res"},{"issue":"1","key":"3239_CR86","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1007\/s10787-022-01083-y","volume":"31","author":"M Shayani Rad","year":"2023","unstructured":"Shayani Rad M, Moohebati M, Mohajeri SA (2023) Beneficial effects of celery seed extract (Apium graveolens), as a supplement, on anxiety and depression in hypertensive patients: a randomized clinical trial. Inflammopharmacology 31(1):395\u2013410. https:\/\/doi.org\/10.1007\/s10787-022-01083-y","journal-title":"Inflammopharmacology"},{"issue":"11","key":"3239_CR87","doi-asserted-by":"publisher","first-page":"e21161","DOI":"10.1016\/j.heliyon.2023.e21161","volume":"9","author":"S Shoukat","year":"2023","unstructured":"Shoukat S, Zia MA, Uzair M, Attia KA, Abushady AM, Fiaz S, Ali S, Yang SH, Ali GM (2023) Bacopa monnieri: a promising herbal approach for neurodegenerative disease treatment supported by in silico and in vitro research. Heliyon 9(11):e21161. https:\/\/doi.org\/10.1016\/j.heliyon.2023.e21161","journal-title":"Heliyon"},{"key":"3239_CR88","doi-asserted-by":"publisher","unstructured":"Shuler MS, Prasad A, Flanagan R, Dayal V, Lithander FE (2026) Nutrition in Parkinson\u2019s disease: what neurologists need to know. Pract Neurol. https:\/\/doi.org\/10.1136\/pn-2025-004998","DOI":"10.1136\/pn-2025-004998"},{"issue":"9","key":"3239_CR90","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1002\/ptr.5116","volume":"28","author":"R Singh","year":"2014","unstructured":"Singh R, Ramakrishna R, Bhateria M, Bhatta RS (2014) In vitro evaluation of Bacopa monniera extract and individual constituents on human recombinant monoamine oxidase enzymes. Phytother Res 28(9):1419\u20131422. https:\/\/doi.org\/10.1002\/ptr.5116","journal-title":"Phytother Res"},{"issue":"8","key":"3239_CR89","doi-asserted-by":"publisher","first-page":"741","DOI":"10.3109\/00498254.2015.1017752","volume":"45","author":"R Singh","year":"2015","unstructured":"Singh R, Rachumallu R, Bhateria M, Panduri J, Bhatta RS (2015) In vitro effects of standardized extract of Bacopa monniera and its five individual active constituents on human P-glycoprotein activity. Xenobiotica 45(8):741\u2013749. https:\/\/doi.org\/10.3109\/00498254.2015.1017752","journal-title":"Xenobiotica"},{"issue":"7","key":"3239_CR91","doi-asserted-by":"publisher","first-page":"e42391","DOI":"10.7759\/cureus.42391","volume":"15","author":"A Sousa","year":"2023","unstructured":"Sousa A, DiFrancisco-Donoghue J (2023) Cannabidiol and tetrahydrocannabinol use in Parkinson\u2019s disease: an observational pilot study. Cureus 15(7):e42391. https:\/\/doi.org\/10.7759\/cureus.42391","journal-title":"Cureus"},{"issue":"1","key":"3239_CR92","doi-asserted-by":"publisher","first-page":"75","DOI":"10.3390\/toxics3010075","volume":"3","author":"BJ Stansley","year":"2015","unstructured":"Stansley BJ, Yamamoto BK (2015) L-Dopa and brain serotonin system dysfunction. Toxics 3(1):75\u201388. https:\/\/doi.org\/10.3390\/toxics3010075","journal-title":"Toxics"},{"key":"3239_CR93","doi-asserted-by":"publisher","unstructured":"Sun S, Yu Y, Jo Y, Han JH, Xue Y, Cho M, Bae S-J, Ryu D, Park W, Ha K-T, Zhuang S (2025) Impact of extraction techniques on phytochemical composition and bioactivity of natural product mixtures. Front Pharmacol. https:\/\/doi.org\/10.3389\/fphar.2025.1615338","DOI":"10.3389\/fphar.2025.1615338"},{"key":"3239_CR94","doi-asserted-by":"publisher","unstructured":"Tan TYC, Lim XY, Norahmad NA, Chanthira Kumar H, Teh BP, Lai NM, Syed Mohamed AF (2023) Neurological applications of celery (Apium graveolens): a scoping review. Molecules 28(15). https:\/\/doi.org\/10.3390\/molecules28155824","DOI":"10.3390\/molecules28155824"},{"issue":"1","key":"3239_CR95","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.apjtb.2016.11.003","volume":"7","author":"S Tanasawet","year":"2017","unstructured":"Tanasawet S, Boonruamkaew P, Sukketsiri W, Chonpathompikunlert P (2017) Anxiolytic and free radical scavenging potential of Chinese celery (Apium graveolens) extract in mice. Asian Pac J Trop Biomed 7(1):20\u201326. https:\/\/doi.org\/10.1016\/j.apjtb.2016.11.003","journal-title":"Asian Pac J Trop Biomed"},{"issue":"1","key":"3239_CR96","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s42238-021-00112-x","volume":"4","author":"TF Thomas","year":"2022","unstructured":"Thomas TF, Metaxas ES, Nguyen T, Bennett W, Skiendzielewski KV, Quinn DH, Scaletta AL (2022) Case report: medical cannabis-warfarin drug-drug interaction. J Cannabis Res 4(1):6. https:\/\/doi.org\/10.1186\/s42238-021-00112-x","journal-title":"J Cannabis Res"},{"issue":"6","key":"3239_CR98","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1007\/s13659-020-00269-7","volume":"10","author":"MJ Uddin","year":"2020","unstructured":"Uddin MJ, Zidorn C (2020) Traditional herbal medicines against CNS disorders from Bangladesh. Nat Prod Bioprospect 10(6):377\u2013410. https:\/\/doi.org\/10.1007\/s13659-020-00269-7","journal-title":"Nat Prod Bioprospect"},{"key":"3239_CR97","unstructured":"U.S. Department of Agriculture, U.S. Department of Health and Human Services (2026) Dietary Guidelines for Americans, 2025\u20132030. 10th edn"},{"issue":"1","key":"3239_CR99","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3233\/jpd-230366","volume":"14","author":"I van der Berg","year":"2024","unstructured":"van der Berg I, Schootemeijer S, Overbeek K, Bloem BR, de Vries NM (2024) Dietary interventions in Parkinson\u2019s disease. J Parkinsons Dis 14(1):1\u201316. https:\/\/doi.org\/10.3233\/jpd-230366","journal-title":"J Parkinsons Dis"},{"issue":"1","key":"3239_CR100","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1080\/14737167.2024.2390042","volume":"25","author":"F van der Meer","year":"2025","unstructured":"van der Meer F, Jorgensen J, Hiligsmann M (2025) Burden of non-motor symptoms of Parkinson\u2019s disease: cost-of-illness and quality-of-life estimates through a scoping review. Expert Rev Pharmacoecon Outcomes Res 25(1):17\u201327. https:\/\/doi.org\/10.1080\/14737167.2024.2390042","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"key":"3239_CR101","doi-asserted-by":"publisher","unstructured":"Wang M, Liu H, Ma Z (2022) Roles of the cannabinoid system in the basal ganglia in Parkinson\u2019s disease. Front Cell Neurosci. https:\/\/doi.org\/10.3389\/fncel.2022.832854","DOI":"10.3389\/fncel.2022.832854"},{"key":"3239_CR102","doi-asserted-by":"publisher","unstructured":"Wei Y, Li H, Li Y, Zeng Y, Quan T, Leng Y, Chang E, Bai Y, Bian Y, Hou Y (2024) Advances of curcumin in nervous system diseases: the effect of regulating oxidative stress and clinical studies. Front Pharmacol 15. https:\/\/doi.org\/10.3389\/fphar.2024.1496661","DOI":"10.3389\/fphar.2024.1496661"},{"key":"3239_CR103","doi-asserted-by":"publisher","unstructured":"Wiesner A, Gajewska D, Pa\u015bko P (2021) Levothyroxine interactions with food and dietary supplements\u2014a systematic review. Pharmaceuticals (Basel) 14(3). https:\/\/doi.org\/10.3390\/ph14030206","DOI":"10.3390\/ph14030206"},{"issue":"8","key":"3239_CR104","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1016\/j.neurobiolaging.2011.03.007","volume":"33","author":"N Xiong","year":"2012","unstructured":"Xiong N, Huang J, Chen C, Zhao Y, Zhang Z, Jia M, Zhang Z, Hou L, Yang H, Cao X, Liang Z, Zhang Y, Sun S, Lin Z, Wang T (2012) Dl-3-n-butylphthalide, a natural antioxidant, protects dopamine neurons in rotenone models for Parkinson\u2019s disease. Neurobiol Aging 33(8):1777\u20131791. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2011.03.007","journal-title":"Neurobiol Aging"},{"key":"3239_CR105","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neuint.2013.12.001","volume":"65","author":"SK Yadav","year":"2014","unstructured":"Yadav SK, Prakash J, Chouhan S, Westfall S, Verma M, Singh TD, Singh SP (2014) Comparison of the neuroprotective potential of Mucuna pruriens seed extract with estrogen in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced PD mice model. Neurochem Int 65:1\u201313. https:\/\/doi.org\/10.1016\/j.neuint.2013.12.001","journal-title":"Neurochem Int"},{"key":"3239_CR106","doi-asserted-by":"publisher","unstructured":"Yin R, Xue J, Tan Y, Fang C, Hu C, Yang Q, Mei X, Qi D (2021) The positive role and mechanism of herbal medicine in Parkinson\u2019s disease. Oxidative Med Cell Longev 2021(9923331). https:\/\/doi.org\/10.1155\/2021\/9923331","DOI":"10.1155\/2021\/9923331"},{"issue":"7","key":"3239_CR107","doi-asserted-by":"publisher","first-page":"1816","DOI":"10.1007\/s11064-022-03591-3","volume":"47","author":"W Zahra","year":"2022","unstructured":"Zahra W, Birla H, Singh SS, Rathore AS, Dilnashin H, Singh R, Keshri PK, Gautam P, Singh SP (2022) Neuroprotection by Mucuna pruriens in neurodegenerative diseases. Neurochem Res 47(7):1816\u20131829. https:\/\/doi.org\/10.1007\/s11064-022-03591-3","journal-title":"Neurochem Res"},{"key":"3239_CR108","doi-asserted-by":"publisher","unstructured":"Zhong L, Cai B, Wang Q, Li X, Xu W, Chen T (2022) Exploring the neuroprotective mechanism of curcumin inhibition of intestinal inflammation against Parkinson\u2019s disease based on the gut-brain axis. Pharmaceuticals (Basel) 16(1). https:\/\/doi.org\/10.3390\/ph16010039","DOI":"10.3390\/ph16010039"},{"issue":"5","key":"3239_CR109","doi-asserted-by":"publisher","first-page":"3800","DOI":"10.3892\/etm.2019.7397","volume":"17","author":"H Zhou","year":"2019","unstructured":"Zhou H, Ye M, Xu W, Yu M, Liu X, Chen Y (2019) DL-3-n-butylphthalide therapy for Parkinson\u2019s disease: a randomized controlled trial. Exp Ther Med 17(5):3800\u20133806. https:\/\/doi.org\/10.3892\/etm.2019.7397","journal-title":"Exp Ther Med"},{"key":"3239_CR110","doi-asserted-by":"publisher","unstructured":"Zuardi A, Crippa J, Hallak J, Pinto J, Chagas M, Rodrigues G, Dursun S, Tumas V (2009) Cannabidiol for the treatment of psychosis in Parkinson\u2019s disease. 23(8):979\u2013983. https:\/\/doi.org\/10.1177\/0269881108096519","DOI":"10.1177\/0269881108096519"}],"container-title":["Journal of Neural Transmission"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-026-03239-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00702-026-03239-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-026-03239-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T14:18:45Z","timestamp":1784816325000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00702-026-03239-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,23]]},"references-count":110,"alternative-id":["3239"],"URL":"https:\/\/doi.org\/10.1007\/s00702-026-03239-4","relation":{},"ISSN":["0300-9564","1435-1463"],"issn-type":[{"value":"0300-9564","type":"print"},{"value":"1435-1463","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,23]]},"assertion":[{"value":"17 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}